BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29914429)

  • 1. Elevated expression of hyaluronan synthase 2 associates with decreased survival in diffusely infiltrating astrocytomas.
    Valkonen M; Haapasalo H; Rilla K; Tyynelä-Korhonen K; Soini Y; Pasonen-Seppänen S
    BMC Cancer; 2018 Jun; 18(1):664. PubMed ID: 29914429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of hyaluronan synthase 1 and 2 associates with poor prognosis in cutaneous melanoma.
    Poukka M; Bykachev A; Siiskonen H; Tyynelä-Korhonen K; Auvinen P; Pasonen-Seppänen S; Sironen R
    BMC Cancer; 2016 May; 16():313. PubMed ID: 27184066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX4 is overexpressed in diffusely infiltrating astrocytoma and confers poor prognosis.
    Li L; Li Q; Chen X; Xu M; Li X; Nie L; Chen N; Gong J; Mao Q; Zhou Q
    Neuropathology; 2015 Dec; 35(6):510-7. PubMed ID: 26096696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsp27 and its expression pattern in diffusely infiltrating astrocytomas.
    Mäkelä KS; Haapasalo JA; Ilvesaro JM; Parkkila S; Paavonen T; Haapasalo HK
    Histol Histopathol; 2014 Sep; 29(9):1161-8. PubMed ID: 24599602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitosin and pHH3 predict poorer survival in astrocytomas WHO grades II and III.
    Varughese RK; Lind-Landström T; Habberstad AH; Salvesen Ø; Haug CS; Sundstrøm S; Torp SH
    J Clin Pathol; 2016 Jan; 69(1):26-34. PubMed ID: 26188054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twist predicts poor outcome of patients with astrocytic glioma.
    Nordfors K; Haapasalo J; Mäkelä K; Granberg KJ; Nykter M; Korja M; Paavonen T; Haapasalo H; Soini Y
    J Clin Pathol; 2015 Nov; 68(11):905-12. PubMed ID: 26163539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement activation in astrocytomas: deposition of C4d and patient outcome.
    Mäkelä K; Helén P; Haapasalo H; Paavonen T
    BMC Cancer; 2012 Dec; 12():565. PubMed ID: 23199209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.
    Shono T; Tofilon PJ; Bruner JM; Owolabi O; Lang FF
    Cancer Res; 2001 Jun; 61(11):4375-81. PubMed ID: 11389063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of an alternatively spliced isoform of carbonic anhydrase XII in diffusely infiltrating astrocytic gliomas.
    Haapasalo J; Hilvo M; Nordfors K; Haapasalo H; Parkkila S; Hyrskyluoto A; Rantala I; Waheed A; Sly WS; Pastorekova S; Pastorek J; Parkkila AK
    Neuro Oncol; 2008 Apr; 10(2):131-8. PubMed ID: 18322268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of carbonic anhydrase IX in astrocytic tumors predicts poor prognosis.
    Haapasalo JA; Nordfors KM; Hilvo M; Rantala IJ; Soini Y; Parkkila AK; Pastoreková S; Pastorek J; Parkkila SM; Haapasalo HK
    Clin Cancer Res; 2006 Jan; 12(2):473-7. PubMed ID: 16428489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heme oxygenase-1 expression in human gliomas and its correlation with poor prognosis in patients with astrocytoma.
    Gandini NA; Fermento ME; Salomón DG; Obiol DJ; Andrés NC; Zenklusen JC; Arevalo J; Blasco J; López Romero A; Facchinetti MM; Curino AC
    Tumour Biol; 2014 Mar; 35(3):2803-15. PubMed ID: 24234335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of vascular adhesion protein-1 is associated with poor prognosis of astrocytomas.
    Kostoro J; Chang SJ; Clark Lai YC; Wu CC; Chai CY; Kwan AL
    APMIS; 2016 Jun; 124(6):462-8. PubMed ID: 26935340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of ALDH1, EZH2 and Ki-67 in Astrocytic Gliomas.
    Ahmed S; Rashed H; Hegazy A; Mohamed AM; Elmesallamy W
    Turk Patoloji Derg; 2016; 32(2):70-81. PubMed ID: 27136105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polysialic acid is associated with better prognosis and IDH1-mutation in diffusely infiltrating astrocytomas.
    Mäkelä K; Nordfors K; Finne J; Jokilammi A; Paavonen T; Haapasalo H; Korja M; Haapasalo J
    BMC Cancer; 2014 Aug; 14():623. PubMed ID: 25164322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of survivin and DNA topoisomerase IIα in diffuse and anaplastic astrocytomas.
    Varughese RK; Skjulsvik AJ; Torp SH
    Pathol Res Pract; 2017 Apr; 213(4):339-347. PubMed ID: 28214203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Manganese superoxide dismutase (MnSOD) is a malignant astrocytoma specific biomarker and associated with adverse prognosis in p53 expressing glioblastoma.
    Shwetha SD; Shastry AH; Arivazhagan A; Santosh V
    Pathol Res Pract; 2016 Jan; 212(1):17-23. PubMed ID: 26616112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue thioredoxin reductase-1 expression in astrocytomas of different grades.
    Esen H; Erdi F; Kaya B; Feyzioglu B; Keskin F; Demir LS
    J Neurooncol; 2015 Feb; 121(3):451-8. PubMed ID: 25391969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High CHI3L1 expression is associated with glioma patient survival.
    Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
    Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of hyaluronan synthase-2 reduces the tumorigenic potential of glioma cells lacking hyaluronidase activity.
    Enegd B; King JA; Stylli S; Paradiso L; Kaye AH; Novak U
    Neurosurgery; 2002 Jun; 50(6):1311-8. PubMed ID: 12015850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NRF2, DJ1 and SNRX1 and their prognostic impact in astrocytic gliomas.
    Haapasalo J; Nordfors K; Granberg KJ; Kivioja T; Nykter M; Haapasalo H; Soini Y
    Histol Histopathol; 2018 Aug; 33(8):791-801. PubMed ID: 29441509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.